Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Rheumatology International
Published in: Rheumatology International 1/2005

01-01-2005 | Letter to the editor

Nerve conduction tests in patients with fibromyalgia syndrome

Authors: Xavier J. Caro, Earl Winter

Published in: Rheumatology International | Issue 1/2005

Login to get access

Excerpt

It is likely that the fibromyalgia syndrome (FMS) is made up of a number of subgroups, each having a unique etiology but all sharing a final common clinical expression. The laboratory identification of one or more of these subgroups would allow better understanding of the syndrome and more specific treatment strategies. …
Literature
1.
Ersoz M (2003) Nerve conduction tests in patients with fibromyalgia: comparison with normal controls. Rheumatol Int 23:166–170CrossRefPubMed
2.
Wolfe F, Anderson J, Harkness D, Bennett RM, Caro XJ, Goldenberg DL et al (1997) A prospective, longitudinal, multicenter study of service utilization and costs in fibromyalgia. Arthritis Rheum 40:1560–1570PubMed
3.
Wolfe F, Ross K, Anderson J, Russell IJ (1995) The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 38:19–28PubMed
4.
O’Brien PC, Dyck PJ (1995) Procedures for setting normal values. Neurology 45:17-23PubMed
5.
Lachman T, Shahani BT, Young RR (1980) Late responses as aids to diagnosis in peripheral neuropathy. J Neurol Neurosurg Psychiatry 43:159–162
6.
Fisher MA (1992) AAEM Minimonograph #13. H reflexes and F waves: physiology and clinical indications. American Association of Electrodiagnostic Medicine, Rochester
Metadata
Title
Nerve conduction tests in patients with fibromyalgia syndrome
Authors
Xavier J. Caro
Earl Winter
Publication date
01-01-2005
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 1/2005
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-004-0445-1

Other articles of this Issue 1/2005

Rheumatology International 1/2005 Go to the issue

Original Article

Decreased serum level of antibody against human cytomegalovirus in patients with Behçet’s disease

Original Article

Cytokine inhibitors: soluble tumor necrosis factor receptor 1 and interleukin-1 receptor antagonist in Behçet’s disease

Case Report

A case of antiphospholipid syndrome presenting with pulmonary truncus and main pulmonary artery thrombosis

Reply to letter to the editor

Nerve conduction tests in patients with fibromyalgia: comparison with normal controls

Original Article

Mud compress therapy for the hands of patients with rheumatoid arthritis

Original Article

Serum homocysteine level is higher in Behçet’s disease with vascular involvement
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits